Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis

World Journal of Gastroenterology

Volumn 16, Issue 6, 2010, Pages 770-777

  Zhang, Yu ^a   Zhou, Jian Hua ^a   Yin, Xiao Ling ^a   Wang, Feng Yu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Drug therapy; Hepatitis B virus associated glomerulonephritis; Meta analysis

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; DIPYRIDAMOLE; DIURETIC AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFECT; GLOMERULONEPHRITIS; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY FUNCTION; META ANALYSIS; MYALGIA; PARESTHESIA; PEDIATRICS; PROTEINURIA; REMISSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 76749131637     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i6.770     Document Type: Article

References (37)

1. Bhimma R, Coovadia HM, Adhikari M, Connolly CA. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy. Arch Pediatr Adolesc Med 2003; 157: 1025-1030
2. Xu H, Sun L, Zhou LJ, Fang LJ, Sheng FY, Guo YQ. The effect of hepatitis B vaccination on the incidence of childhood HBV-associated nephritis. Pediatr Nephrol 2003; 18: 1216-1219
3. Walters S, Levin M. Infectious diseases and the kidney. In: Barratt TM, Avner ED, Harmon WE, editors. Pediatric Nephrology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999: 1088-1090
4. Lai KN, Lai FM, Chan KW, Chow CB, Tong KL, Vallance-Owen J. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 1987; 63: 323-333
5. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994; 8: 11-14
6. Lin CY. Hepatitis B virus-associated membraneous nephropathy: clinical features, immunological profiles and outcome. Nephron 1990; 55: 37-44
7. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004; 24: 198-211
8. Zhou JH, Zhang Y. Treatment of Hepatitis B Virus Associated Nephritis in Children. Shiyong Erke Linchuang Zazhi 2008; 23: 329-332
9. Chung DR, Yang WS, Kim SB, Yu E, Chung YH, Lee Y, Park JS. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997; 17: 112-117
10. Wong SN, Yu EC, Lok AS, Chan KW, Lau YL. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 1992; 6: 417-420
11. Appel GB, Radhakrishnan J, D'Agati V. Secondary glomerular disease. In: Brenner BM, editor. The Kidney. 6th ed. Philadelphia, PA: WB Saunders, 2000: 1411
12. Fabrizi F, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther 2006; 24: 781-788
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101
16. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995; 47: 225-230
17. Bhimma R, Coovadia HM, Kramvis A, Adhikari M, Kew MC. Treatment of hepatitis B virus-associated nephropathy in black children. Pediatr Nephrol 2002; 17: 393-399
18. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-1463
19. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005; 68: 1750-1758
20. Panomsak S, Lewsuwan S, Eiam-Ong S, Kanjanabuch T. Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. J Med Assoc Thai 2006; 89 Suppl 2: S151-S156
21. Yang Q, Zhuang JQ, Lin RX, Yang YZ, Wang ZX. Clinicopathological Features and Treatment of Hepatitis B Virus Associated Membranous Nephropathy in Children. Zhongguo Zhongxiyi Jiehe Shenbing Zazhi 2003; 4: 706-708
22. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990; 54: 12-17
23. Ozdamar SO, Gucer S, Tinaztepe K. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children. Pediatr Nephrol 2003; 18: 23-28
24. Peña A, Débora MJ, Melgosa M, Luz Picazo M, Navarro M. Membranous nephropathy associated with hepatitis B in Spanish children. Clin Nephrol 2001; 55: 25-30
25. Shapiro RJ, Steinbrecher UP, Magil A. Remission of nephrotic syndrome of HBV-associated membranous glomerulopathy following treatment with interferon. Am J Nephrol 1995; 15: 343-347
26. Kavukçu S, Başdemir G, Eroǧlu Y, Türkmen M, Eser F, Büyükgebiz B. Interferon treatment in hepatitis B virus-associated membranous glomerulopathy. Pediatr Nephrol 1995; 9: 539-540
27. Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995; 109: 540-546
28. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 2003; 88: 446-449
29. Filler G, Feber J, Weiler G, Le Saux N. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child 2003; 88: 460
30. Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic Hepatitis B infection. Can J Gastroenterol 2005; 19: 625-629
31. Kanaan N, Horsmans Y, Goffin E. Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Clin Nephrol 2006; 65: 208-210
32. Okuse C, Yotsuyanagi H, Yamada N, Ikeda H, Takahashi H, Suzuki M, Kondo S, Kimura K, Koike J, Itoh F. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clin Nephrol 2006; 65: 53-56
33. Wen YK, Chen ML. Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy. Clin Nephrol 2006; 65: 211-215
34. Taskapan H, Oymak O, Dogukan A, Ozbakir O, Utas C. Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 2000; 54: 161-163
35. Lai FM, Tam JS, Li PK, Lai KN. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 1989; 414: 279-284
36. Lin CY. Clinical features and natural course of HBV-related glomerulopathy in children. Kidney Int Suppl 1991; 35: S46-S53
37. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000; 53: 207-216